Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02912780
Other study ID # COHORT2013
Secondary ID
Status Recruiting
Phase N/A
First received September 14, 2016
Last updated September 21, 2016
Start date January 2013
Est. completion date December 2017

Study information

Verified date September 2016
Source McMaster Children's Hospital
Contact Christoph Fusch, MD, PhD
Phone +1-905-527-6342
Email fusch@mcmaster.ca
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Observational

Clinical Trial Summary

The advancement in life-saving technologies and clinical expertise in the care of extremely premature infants, have resulted in the development of large neonatal intensive care units (NICU). It has been suggested that reconstruction of megaunits of neonatal intensive care to smaller care units with specific patient population and clinical team providers will be essential to maintain optimal teamwork, quality of care and patient outcome.

Despite the growing knowledge around the need for reconstruction of large NICUs to smaller units of care, there is no evidence regarding the safety and efficacy of microsystem model of care on the key aspects of health care. At the McMaster Children's Hospital (MCH), we planned a change from standard model of care to the microsystem model of care and therefore we aimed to prospectively assess the effect of this organizational change on the variable aspects of health care.

A working group met weekly to formulate the implementation planning, to review the adaptation and adjustment process and to ascertain the quality of implementation following the initiation of the microsystem model.

The study was retrospectively registered.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion criteria:

- All preterm and term infants admitted to McMaster Children's Hospital NICU

Exclusion criteria:

- no exclusion criteria

Study Design

Time Perspective: Prospective


Locations

Country Name City State
Canada Faculty of Health Science, McMaster Children's Hospital Hamilton Ontario

Sponsors (1)

Lead Sponsor Collaborator
McMaster Children's Hospital

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of stress level of Health Care Professional - Salivary cortisol (ng/dL) once every week, up to 3 month corrected age No
Primary Change of stress level of Parents - Salivary cortisol (ng/dL) once every week, up to 3 month corrected age No
Primary Change of stress level of Patients - Salivary cortisol (ng/dL) once every week, up to 3 month corrected age No
Primary Length of stay - days up to 3 month corrected age No
Primary Incidence of necrotizing enterocolitis up to 3 month corrected age No
Primary Incidence of retinopathia of prematurity up to 3 month corrected age No
Primary Incidence of bronchopulmonary dysplasia up to 3 month corrected age No
Primary Incidence of sepsis up to 3 month corrected age No
Primary Duration of mechanical ventilation - days up to 3 month corrected age No
Primary Time of feed initiation - days up to 3 month corrected age No
Primary Time to full feed - days up to 3 month corrected age No
Primary Number of days with parenteral nutrition up to 3 month corrected age No
Primary Bayley scale - Psychomotor Developmental Index up to 3 month corrected age No
Primary Bayley scale - Mental Developmental Index up to 3 month corrected age No
Primary Number of changes in the primary health care professionals up to 3 month corrected age No
Primary Noise level (decibel) up to 3 month corrected age No
Primary use of resources (lab tests, X-rays, microbiological tests) number of procedures up to 3 month corrected age No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04046913 - The ADDapt Diet in Reducing Crohn's Disease Inflammation N/A
Active, not recruiting NCT04989907 - A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Active, not recruiting NCT04990258 - A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
Completed NCT06216223 - Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients N/A
Enrolling by invitation NCT06015789 - Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
Recruiting NCT06065995 - StoMakker Mobile Application N/A
Recruiting NCT03282786 - Comparison of Carbon Dioxide (CO2) to Air Insufflation in Colonoscopy in Patients With Inflammatory Bowel Disease N/A
Recruiting NCT06002074 - SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases N/A
Recruiting NCT04960826 - Study of an Environmental Risk Factor in Crohn's Disease
Recruiting NCT05413941 - Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease N/A
Completed NCT03668249 - A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
Completed NCT00721812 - A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 Phase 1
Recruiting NCT05809999 - IBD Neoplasia Surveillance RCT N/A
Recruiting NCT04138225 - The Ecological Role of Yeasts in the Human Gut
Recruiting NCT04991324 - Cholecalciferol Comedication in IBD - the 5C-study Phase 3
Completed NCT03173144 - Chronic Inflammatory Disease, Lifestyle and Treatment Response
Not yet recruiting NCT05043818 - A Clinical Study on the Screening of Intestinal Biomarkers in IBD Patients With Depression
Recruiting NCT03042091 - Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery Early Phase 1
Completed NCT02874365 - Intestinal Stem Cells Characterization N/A